Tivic Health Systems (NASDAQ:TIVC – Get Free Report) and Omnicell (NASDAQ:OMCL – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, dividends, risk, profitability, institutional ownership, valuation and analyst recommendations.
Earnings and Valuation
This table compares Tivic Health Systems and Omnicell”s gross revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Tivic Health Systems | $780,000.00 | 3.69 | -$5.66 million | ($6.68) | -0.15 |
| Omnicell | $1.18 billion | 1.31 | $2.05 million | $0.04 | 853.75 |
Profitability
This table compares Tivic Health Systems and Omnicell’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Tivic Health Systems | -1,557.26% | -202.20% | -173.34% |
| Omnicell | 0.17% | 3.00% | 1.81% |
Institutional & Insider Ownership
4.3% of Tivic Health Systems shares are owned by institutional investors. Comparatively, 97.7% of Omnicell shares are owned by institutional investors. 2.4% of Tivic Health Systems shares are owned by company insiders. Comparatively, 2.5% of Omnicell shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Risk & Volatility
Tivic Health Systems has a beta of 1.84, indicating that its share price is 84% more volatile than the S&P 500. Comparatively, Omnicell has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500.
Analyst Ratings
This is a breakdown of recent ratings and target prices for Tivic Health Systems and Omnicell, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Tivic Health Systems | 1 | 0 | 0 | 0 | 1.00 |
| Omnicell | 1 | 1 | 6 | 0 | 2.63 |
Omnicell has a consensus target price of $58.50, suggesting a potential upside of 71.30%. Given Omnicell’s stronger consensus rating and higher probable upside, analysts clearly believe Omnicell is more favorable than Tivic Health Systems.
Summary
Omnicell beats Tivic Health Systems on 12 of the 14 factors compared between the two stocks.
About Tivic Health Systems
Tivic Health Systems Inc. operates as a health tech company, focuses on developing and commercializing bioelectronic medicine. Its primary product is ClearUP, a bioelectronic medicine for the treatment of sinus and nasal inflammation. The company sells its products on direct-to-consumer channel through its own websites; and platforms, such as Amazon.com and Walmart.com, as well as to U.S. online retailers, such as BestBuy and FSAStore and through distributors. Tivic Health Systems, Inc. was incorporated in 2016 and is headquartered in Hayward, California.
About Omnicell
Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.
Receive News & Ratings for Tivic Health Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivic Health Systems and related companies with MarketBeat.com's FREE daily email newsletter.
